{
    "medicine_id": "6756601a43bd336ccc7747036228d5a8dd775c77",
    "platform_id": "DB01377",
    "metadata": {
        "name": "Active FE 440 mg Capsule",
        "composition": "440 mg Magnesium oxide",
        "clinical_particulars": {
            "therapeutic_indications": "Indicated for over the counter use as a supplement for cardiovascular and neuromuscular health and as an antacid for relief of acid indigestion and upset stomach",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00202",
                        "description": "The therapeutic efficacy of Succinylcholine can be increased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00416",
                        "description": "The therapeutic efficacy of Metocurine iodide can be increased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00483",
                        "description": "The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00565",
                        "description": "The therapeutic efficacy of Cisatracurium can be increased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00728",
                        "description": "The therapeutic efficacy of Rocuronium can be increased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00732",
                        "description": "The therapeutic efficacy of Atracurium besylate can be increased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01135",
                        "description": "The therapeutic efficacy of Doxacurium can be increased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01226",
                        "description": "The therapeutic efficacy of Mivacurium can be increased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01245",
                        "description": "The therapeutic efficacy of Decamethonium can be increased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01336",
                        "description": "The therapeutic efficacy of Metocurine can be increased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "The therapeutic efficacy of Pancuronium can be increased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01338",
                        "description": "The therapeutic efficacy of Pipecuronium can be increased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01339",
                        "description": "The therapeutic efficacy of Vecuronium can be increased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB04834",
                        "description": "The therapeutic efficacy of Rapacuronium can be increased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB11156",
                        "description": "The therapeutic efficacy of Pyrantel can be increased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB12989",
                        "description": "The therapeutic efficacy of Neosaxitoxin can be increased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13295",
                        "description": "The therapeutic efficacy of Atracurium can be increased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13584",
                        "description": "The therapeutic efficacy of Gallamine can be increased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13648",
                        "description": "The therapeutic efficacy of Alcuronium can be increased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01199",
                        "description": "The therapeutic efficacy of Tubocurarine can be increased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01066",
                        "description": "The serum concentration of Cefditoren can be decreased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Dabigatran etexilate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00705",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Delavirdine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Erlotinib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Itraconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09027",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Ledipasvir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "Magnesium oxide can cause an increase in the absorption of Methylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00136",
                        "description": "The serum concentration of Magnesium oxide can be increased when it is combined with Calcitriol"
                    },
                    {
                        "drugbank-id": "DB00146",
                        "description": "The serum concentration of Magnesium oxide can be increased when it is combined with Calcifediol"
                    },
                    {
                        "drugbank-id": "DB00910",
                        "description": "The serum concentration of Magnesium oxide can be increased when it is combined with Paricalcitol"
                    },
                    {
                        "drugbank-id": "DB01070",
                        "description": "The serum concentration of Magnesium oxide can be increased when it is combined with Dihydrotachysterol"
                    },
                    {
                        "drugbank-id": "DB01436",
                        "description": "The serum concentration of Magnesium oxide can be increased when it is combined with Alfacalcidol"
                    },
                    {
                        "drugbank-id": "DB04258",
                        "description": "The serum concentration of Magnesium oxide can be increased when it is combined with Seocalcitol"
                    },
                    {
                        "drugbank-id": "DB04796",
                        "description": "The serum concentration of Magnesium oxide can be increased when it is combined with Inecalcitol"
                    },
                    {
                        "drugbank-id": "DB04891",
                        "description": "The serum concentration of Magnesium oxide can be increased when it is combined with Becocalcidiol"
                    },
                    {
                        "drugbank-id": "DB05295",
                        "description": "The serum concentration of Magnesium oxide can be increased when it is combined with Eldecalcitol"
                    },
                    {
                        "drugbank-id": "DB06117",
                        "description": "The serum concentration of Magnesium oxide can be increased when it is combined with 1alpha 24S Dihydroxyvitamin D2"
                    },
                    {
                        "drugbank-id": "DB06194",
                        "description": "The serum concentration of Magnesium oxide can be increased when it is combined with Elocalcitol"
                    },
                    {
                        "drugbank-id": "DB06272",
                        "description": "The serum concentration of Magnesium oxide can be increased when it is combined with Maxacalcitol"
                    },
                    {
                        "drugbank-id": "DB06410",
                        "description": "The serum concentration of Magnesium oxide can be increased when it is combined with Doxercalciferol"
                    },
                    {
                        "drugbank-id": "DB13097",
                        "description": "The serum concentration of Magnesium oxide can be increased when it is combined with 1alpha Hydroxyvitamin D5"
                    },
                    {
                        "drugbank-id": "DB08826",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Deferiprone resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08930",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06210",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00451",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01344",
                        "description": "The risk or severity of adverse effects can be increased when Tolevamer is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB09020",
                        "description": "The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01416",
                        "description": "The serum concentration of Cefpodoxime can be decreased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01112",
                        "description": "The serum concentration of Cefuroxime can be decreased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Chloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09101",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Elvitegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08872",
                        "description": "The serum concentration of Gabapentin enacarbil can be decreased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01045",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Rifampicin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "Magnesium oxide may decrease the excretion rate of Mecamylamine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01043",
                        "description": "Magnesium oxide may decrease the excretion rate of Memantine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00859",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Penicillamine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "Magnesium oxide may decrease the excretion rate of Quinidine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Quinine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "The serum concentration of Sotalol can be decreased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The therapeutic efficacy of Sulpiride can be increased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01609",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Deferasirox resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00437",
                        "description": "The therapeutic efficacy of Allopurinol can be decreased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00950",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Fexofenadine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06817",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00929",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Misoprostol"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01024",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Mycophenolic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00847",
                        "description": "The bioavailability of Cysteamine can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Tramadol"
                    },
                    {
                        "drugbank-id": "DB00209",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Trospium"
                    },
                    {
                        "drugbank-id": "DB00219",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Oxyphenonium"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Benzatropine"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Ziprasidone"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Amitriptyline"
                    },
                    {
                        "drugbank-id": "DB00332",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Ipratropium"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Olanzapine"
                    },
                    {
                        "drugbank-id": "DB00340",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Metixene"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Terfenadine"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Buclizine"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Clozapine"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Doxylamine"
                    },
                    {
                        "drugbank-id": "DB00376",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Trihexyphenidyl"
                    },
                    {
                        "drugbank-id": "DB00383",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Oxyphencyclimine"
                    },
                    {
                        "drugbank-id": "DB00387",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Procyclidine"
                    },
                    {
                        "drugbank-id": "DB00392",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Profenamine"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Cyproheptadine"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Imipramine"
                    },
                    {
                        "drugbank-id": "DB00462",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Methscopolamine bromide"
                    },
                    {
                        "drugbank-id": "DB00496",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Darifenacin"
                    },
                    {
                        "drugbank-id": "DB00505",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Tridihexethyl"
                    },
                    {
                        "drugbank-id": "DB00517",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Anisotropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Nortriptyline"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Amoxapine"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Atropine"
                    },
                    {
                        "drugbank-id": "DB00670",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Pirenzepine"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Paroxetine"
                    },
                    {
                        "drugbank-id": "DB00725",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Homatropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00747",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Scopolamine"
                    },
                    {
                        "drugbank-id": "DB00767",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Benzquinamide"
                    },
                    {
                        "drugbank-id": "DB00771",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Clidinium"
                    },
                    {
                        "drugbank-id": "DB00777",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Propiomazine"
                    },
                    {
                        "drugbank-id": "DB00782",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Propantheline"
                    },
                    {
                        "drugbank-id": "DB00804",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Dicyclomine"
                    },
                    {
                        "drugbank-id": "DB00810",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Biperiden"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Brompheniramine"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Flupentixol"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Cocaine"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00940",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Methantheline"
                    },
                    {
                        "drugbank-id": "DB00942",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Cycrimine"
                    },
                    {
                        "drugbank-id": "DB00986",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Glycopyrronium"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Tolterodine"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Oxybutynin"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Diphenhydramine"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Doxepin"
                    },
                    {
                        "drugbank-id": "DB01148",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Flavoxate"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Desipramine"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Orphenadrine"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Quetiapine"
                    },
                    {
                        "drugbank-id": "DB01231",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Diphenidol"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Aripiprazole"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Chlorprothixene"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Tiotropium"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Solifenacin"
                    },
                    {
                        "drugbank-id": "DB01625",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Isopropamide"
                    },
                    {
                        "drugbank-id": "DB04843",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Mepenzolate"
                    },
                    {
                        "drugbank-id": "DB06153",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Pizotifen"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Fesoterodine"
                    },
                    {
                        "drugbank-id": "DB06787",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Hexocyclium"
                    },
                    {
                        "drugbank-id": "DB08801",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Dimetindene"
                    },
                    {
                        "drugbank-id": "DB08897",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Aclidinium"
                    },
                    {
                        "drugbank-id": "DB08997",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Dexetimide"
                    },
                    {
                        "drugbank-id": "DB09023",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Benactyzine"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Umeclidinium"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Dosulepin"
                    },
                    {
                        "drugbank-id": "DB09262",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Imidafenacin"
                    },
                    {
                        "drugbank-id": "DB09300",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Butylscopolamine"
                    },
                    {
                        "drugbank-id": "DB11235",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Thonzylamine"
                    },
                    {
                        "drugbank-id": "DB11315",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Methscopolamine"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Revefenacin"
                    },
                    {
                        "drugbank-id": "DB12086",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Oxitropium"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Propiverine"
                    },
                    {
                        "drugbank-id": "DB12526",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Batefenterol"
                    },
                    {
                        "drugbank-id": "DB12554",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Mebeverine"
                    },
                    {
                        "drugbank-id": "DB13252",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Tropatepine"
                    },
                    {
                        "drugbank-id": "DB13254",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Prifinium"
                    },
                    {
                        "drugbank-id": "DB13351",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Piperidolate"
                    },
                    {
                        "drugbank-id": "DB13369",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Benzilone"
                    },
                    {
                        "drugbank-id": "DB13380",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Difemerine"
                    },
                    {
                        "drugbank-id": "DB13413",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Phenglutarimide"
                    },
                    {
                        "drugbank-id": "DB13448",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Mazaticol"
                    },
                    {
                        "drugbank-id": "DB13468",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Etybenzatropine"
                    },
                    {
                        "drugbank-id": "DB13505",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Emepronium"
                    },
                    {
                        "drugbank-id": "DB13507",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Poldine"
                    },
                    {
                        "drugbank-id": "DB13542",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Bevonium"
                    },
                    {
                        "drugbank-id": "DB13581",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Rociverine"
                    },
                    {
                        "drugbank-id": "DB13619",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Bornaprine"
                    },
                    {
                        "drugbank-id": "DB13636",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Etanautine"
                    },
                    {
                        "drugbank-id": "DB13666",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Tiemonium iodide"
                    },
                    {
                        "drugbank-id": "DB13678",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Dihexyverine"
                    },
                    {
                        "drugbank-id": "DB13695",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Penthienate"
                    },
                    {
                        "drugbank-id": "DB13720",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Diphemanil"
                    },
                    {
                        "drugbank-id": "DB13738",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Camylofin"
                    },
                    {
                        "drugbank-id": "DB13759",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Fenpiverinium"
                    },
                    {
                        "drugbank-id": "DB13769",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Emetonium iodide"
                    },
                    {
                        "drugbank-id": "DB13844",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Pipenzolate"
                    },
                    {
                        "drugbank-id": "DB13850",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Timepidium"
                    },
                    {
                        "drugbank-id": "DB09007",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Chlorphenoxamine"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Moxifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Enoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Pefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Trovafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Nalidixic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Rosoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Cinoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Lomefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Levofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Temafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Technetium Tc 99m ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Garenoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Nemonoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11404",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Enrofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Orbifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Sarafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Difloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Pazufloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Prulifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Oxolinic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Rufloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Pipemidic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00256",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Lymecycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00453",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Clomocycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00595",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00618",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00759",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00931",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01017",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12035",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Sarecycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12455",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Omadacycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13264",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Penimepicycline resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Thiethylperazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Prochlorperazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Thioridazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Moricizine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Trifluoperazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Perphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01063",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Acetophenazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Alimemazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Periciazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Acepromazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Aceprometazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Pipotiazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Thioproperazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB05687",
                        "description": "Magnesium oxide can cause a decrease in the absorption of BL 1020 resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09000",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Cyamemazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Methylene blue resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11540",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Propiopromazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12710",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Perazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13213",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Butaperazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13382",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Chlorproethazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13420",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Thiazinam resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13784",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Dixyrazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14651",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Perphenazine enanthate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "Promazine can cause a decrease in the absorption of Magnesium oxide resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "Chlorpromazine can cause a decrease in the absorption of Magnesium oxide resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "Triflupromazine can cause a decrease in the absorption of Magnesium oxide resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "Promethazine can cause a decrease in the absorption of Magnesium oxide resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "Methotrimeprazine can cause a decrease in the absorption of Magnesium oxide resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06799",
                        "description": "The therapeutic efficacy of Methenamine can be decreased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB06824",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Triethylenetetramine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01098",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00282",
                        "description": "The serum concentration of Pamidronic acid can be decreased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00399",
                        "description": "The serum concentration of Zoledronic acid can be decreased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00630",
                        "description": "The serum concentration of Alendronic acid can be decreased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The serum concentration of Ibandronate can be decreased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00720",
                        "description": "The serum concentration of Clodronic acid can be decreased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00884",
                        "description": "The serum concentration of Risedronic acid can be decreased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01077",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01133",
                        "description": "The serum concentration of Tiludronic acid can be decreased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB06255",
                        "description": "The serum concentration of Incadronic acid can be decreased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The bioavailability of Betamethasone can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The bioavailability of Fluticasone propionate can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The bioavailability of Triamcinolone can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "The bioavailability of Prednisone can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00687",
                        "description": "The bioavailability of Fludrocortisone can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00741",
                        "description": "The bioavailability of Hydrocortisone can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00860",
                        "description": "The bioavailability of Prednisolone can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00959",
                        "description": "The bioavailability of Methylprednisolone can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01108",
                        "description": "The bioavailability of Trilostane can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "The bioavailability of Budesonide can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The bioavailability of Dexamethasone can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01380",
                        "description": "The bioavailability of Cortisone acetate can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01384",
                        "description": "The bioavailability of Paramethasone can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB04630",
                        "description": "The bioavailability of Aldosterone can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB08970",
                        "description": "The bioavailability of Fluprednidene can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB09378",
                        "description": "The bioavailability of Fluprednisolone can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB09383",
                        "description": "The bioavailability of Meprednisone can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB11487",
                        "description": "The bioavailability of Dexamethasone isonicotinate can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB11529",
                        "description": "The bioavailability of Melengestrol can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB11921",
                        "description": "The bioavailability of Deflazacort can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13003",
                        "description": "The bioavailability of Cortivazol can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13208",
                        "description": "The bioavailability of Prednylidene can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13223",
                        "description": "The bioavailability of Fluocortin can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13491",
                        "description": "The bioavailability of Fluperolone can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13843",
                        "description": "The bioavailability of Cloprednol can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13856",
                        "description": "The bioavailability of Fluclorolone can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB14541",
                        "description": "The bioavailability of Hydrocortisone cypionate can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB14631",
                        "description": "The bioavailability of Prednisolone phosphate can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB14646",
                        "description": "The bioavailability of Prednisone acetate can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB14652",
                        "description": "The bioavailability of Clocortolone acetate can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB14659",
                        "description": "The bioavailability of Melengestrol acetate can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB14669",
                        "description": "The bioavailability of Betamethasone phosphate can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB14681",
                        "description": "The bioavailability of Cortisone can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01013",
                        "description": "The bioavailability of Clobetasol propionate can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01047",
                        "description": "The bioavailability of Fluocinonide can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB14512",
                        "description": "The bioavailability of Mometasone furoate can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB14540",
                        "description": "The bioavailability of Hydrocortisone butyrate can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01410",
                        "description": "The bioavailability of Ciclesonide can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00547",
                        "description": "The bioavailability of Desoximetasone can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB08906",
                        "description": "The bioavailability of Fluticasone furoate can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00591",
                        "description": "The bioavailability of Fluocinolone acetonide can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB08971",
                        "description": "The bioavailability of Fluocortolone can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00394",
                        "description": "The bioavailability of Beclomethasone dipropionate can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "The bioavailability of Difluocortolone can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The risk or severity of hypotension can be increased when Isradipine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The risk or severity of hypotension can be increased when Diltiazem is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of hypotension can be increased when Trimethadione is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00381",
                        "description": "The risk or severity of hypotension can be increased when Amlodipine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "The risk or severity of hypotension can be increased when Nimodipine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "The risk or severity of hypotension can be increased when Nisoldipine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "The risk or severity of hypotension can be increased when Lercanidipine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The risk or severity of hypotension can be increased when Cinnarizine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of hypotension can be increased when Ethosuximide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The risk or severity of hypotension can be increased when Verapamil is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The risk or severity of hypotension can be increased when Loperamide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The risk or severity of hypotension can be increased when Zonisamide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The risk or severity of hypotension can be increased when Felodipine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "The risk or severity of hypotension can be increased when Nitrendipine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The risk or severity of hypotension can be increased when Perhexiline is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The risk or severity of hypotension can be increased when Nifedipine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The risk or severity of hypotension can be increased when Amiodarone is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The risk or severity of hypotension can be increased when Carvedilol is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The risk or severity of hypotension can be increased when Bepridil is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The risk or severity of hypotension can be increased when Mibefradil is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "The risk or severity of hypotension can be increased when Nimesulide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "The risk or severity of hypotension can be increased when Prenylamine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB04838",
                        "description": "The risk or severity of hypotension can be increased when Cyclandelate is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "The risk or severity of hypotension can be increased when Flunarizine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of hypotension can be increased when Fluspirilene is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "The risk or severity of hypotension can be increased when Clevidipine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of hypotension can be increased when Methsuximide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB05885",
                        "description": "The risk or severity of hypotension can be increased when Seletracetam is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "The risk or severity of hypotension can be increased when Nylidrin is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "The risk or severity of hypotension can be increased when Ziconotide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB06446",
                        "description": "The risk or severity of hypotension can be increased when Dotarizine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The risk or severity of hypotension can be increased when Nilvadipine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "The risk or severity of hypotension can be increased when Tranilast is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB08162",
                        "description": "The risk or severity of hypotension can be increased when Fasudil is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB08838",
                        "description": "The risk or severity of hypotension can be increased when Agmatine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "The risk or severity of hypotension can be increased when Fendiline is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of hypotension can be increased when Eperisone is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "The risk or severity of hypotension can be increased when Pinaverium is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "The risk or severity of hypotension can be increased when Tolfenamic acid is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB09227",
                        "description": "The risk or severity of hypotension can be increased when Barnidipine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "The risk or severity of hypotension can be increased when Aranidipine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB09230",
                        "description": "The risk or severity of hypotension can be increased when Azelnidipine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The risk or severity of hypotension can be increased when Benidipine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB09232",
                        "description": "The risk or severity of hypotension can be increased when Cilnidipine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB09234",
                        "description": "The risk or severity of hypotension can be increased when Darodipine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "The risk or severity of hypotension can be increased when Efonidipine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "The risk or severity of hypotension can be increased when Lacidipine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "The risk or severity of hypotension can be increased when Manidipine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The risk or severity of hypotension can be increased when Niguldipine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB09240",
                        "description": "The risk or severity of hypotension can be increased when Niludipine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB11960",
                        "description": "The risk or severity of hypotension can be increased when Carboxyamidotriazole is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "The risk or severity of hypotension can be increased when Naftopidil is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of hypotension can be increased when Tetrahydropalmatine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "The risk or severity of hypotension can be increased when Vinpocetine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "The risk or severity of hypotension can be increased when Gallopamil is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "The risk or severity of hypotension can be increased when Bencyclane is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "The risk or severity of hypotension can be increased when Terodiline is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "The risk or severity of hypotension can be increased when Lidoflazine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of hypotension can be increased when Penfluridol is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13835",
                        "description": "The risk or severity of hypotension can be increased when Caroverine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "The risk or severity of hypotension can be increased when WIN 55212 2 is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "The risk or severity of hypotension can be increased when Dexverapamil is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB14064",
                        "description": "The risk or severity of hypotension can be increased when Emopamil is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB14065",
                        "description": "The risk or severity of hypotension can be increased when Lomerizine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB14066",
                        "description": "The risk or severity of hypotension can be increased when Tetrandrine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "The risk or severity of hypotension can be increased when Dexniguldipine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The risk or severity of hypotension can be increased when Lamotrigine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The risk or severity of hypotension can be increased when Nicardipine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "The risk or severity of hypotension can be increased when Trimebutine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of hypotension can be increased when Otilonium is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The serum concentration of Amphetamine can be increased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The serum concentration of Phentermine can be increased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "The serum concentration of Pseudoephedrine can be increased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "The serum concentration of Benzphetamine can be increased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "The serum concentration of Diethylpropion can be increased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "The serum concentration of Lisdexamfetamine can be increased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "The serum concentration of Mephentermine can be increased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "The serum concentration of MMDA can be increased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "The serum concentration of Midomafetamine can be increased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "The serum concentration of 2 5 Dimethoxy 4 ethylamphetamine can be increased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "The serum concentration of 4 Bromo 2 5 dimethoxyamphetamine can be increased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "The serum concentration of Tenamfetamine can be increased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "The serum concentration of Chlorphentermine can be increased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01566",
                        "description": "The serum concentration of Methylenedioxyethamphetamine can be increased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "The serum concentration of Dextroamphetamine can be increased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "The serum concentration of Metamfetamine can be increased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "The serum concentration of Iofetamine I 123 can be increased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "The serum concentration of Ritobegron can be increased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "The serum concentration of Mephedrone can be increased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "The serum concentration of Methoxyphenamine can be increased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "The serum concentration of Gepefrine can be increased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "The serum concentration of 2 5 Dimethoxy 4 ethylthioamphetamine can be increased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB06783",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Prussian blue resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09146",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Iron sucrose resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09501",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Ferric ammonium citrate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09507",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Ferumoxsil resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09508",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Ferumoxides resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11171",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Ferric sulfate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11417",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Gleptoferron resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12821",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Perflubutane resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13257",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Ferrous sulfate anhydrous resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13381",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Sodium feredetate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13423",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Ferric hydroxide resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13949",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Ferric cation resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14488",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Ferrous gluconate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14489",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Ferrous succinate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14520",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Tetraferric tricitrate decahydrate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14695",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Ferric oxyhydroxide resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00893",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB15598",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Ferric maltol resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14523",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Phosphate ion resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB02369",
                        "description": "Magnesium oxide can cause a decrease in the absorption of 3 Aza 2 3 Dihydrogeranyl Diphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB02423",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Thiopyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB02552",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Geranyl Diphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB04160",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Pyrophosphoric acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB05143",
                        "description": "Magnesium oxide can cause a decrease in the absorption of OXI 4503 resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Geranylgeranyl diphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09147",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Ferric pyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09413",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Monopotassium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09414",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Dipotassium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09449",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Sodium phosphate monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11348",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Calcium Phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11493",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Sodium tripolyphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13995",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Ferric pyrophosphate citrate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14481",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Calcium phosphate dihydrate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "The risk or severity of adverse effects can be increased when Torasemide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00310",
                        "description": "The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00311",
                        "description": "The risk or severity of adverse effects can be increased when Ethoxzolamide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00384",
                        "description": "The risk or severity of adverse effects can be increased when Triamterene is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00421",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00524",
                        "description": "The risk or severity of adverse effects can be increased when Metolazone is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00562",
                        "description": "The risk or severity of adverse effects can be increased when Benzthiazide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00594",
                        "description": "The risk or severity of adverse effects can be increased when Amiloride is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "The risk or severity of adverse effects can be increased when Cyclothiazide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "The risk or severity of adverse effects can be increased when Furosemide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "The risk or severity of adverse effects can be increased when Eplerenone is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00703",
                        "description": "The risk or severity of adverse effects can be increased when Methazolamide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00742",
                        "description": "The risk or severity of adverse effects can be increased when Mannitol is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The risk or severity of adverse effects can be increased when Indapamide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "The risk or severity of adverse effects can be increased when Acetazolamide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "The risk or severity of adverse effects can be increased when Conivaptan is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "The risk or severity of adverse effects can be increased when Chlorothiazide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00887",
                        "description": "The risk or severity of adverse effects can be increased when Bumetanide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00903",
                        "description": "The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "The risk or severity of adverse effects can be increased when Trichlormethiazide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01119",
                        "description": "The risk or severity of adverse effects can be increased when Diazoxide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01144",
                        "description": "The risk or severity of adverse effects can be increased when Diclofenamide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "The risk or severity of adverse effects can be increased when Polythiazide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01325",
                        "description": "The risk or severity of adverse effects can be increased when Quinethazone is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "The risk or severity of adverse effects can be increased when Drospirenone is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01412",
                        "description": "The risk or severity of adverse effects can be increased when Theobromine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB02925",
                        "description": "The risk or severity of adverse effects can be increased when Piretanide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB04831",
                        "description": "The risk or severity of adverse effects can be increased when Tienilic acid is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB05034",
                        "description": "The risk or severity of adverse effects can be increased when Ularitide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "The risk or severity of adverse effects can be increased when Tolvaptan is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB06370",
                        "description": "The risk or severity of adverse effects can be increased when Indisulam is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB08961",
                        "description": "The risk or severity of adverse effects can be increased when Azosemide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB09015",
                        "description": "The risk or severity of adverse effects can be increased when Canrenoic acid is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB09338",
                        "description": "The risk or severity of adverse effects can be increased when Mersalyl is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB09401",
                        "description": "The risk or severity of adverse effects can be increased when Isosorbide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB12221",
                        "description": "The risk or severity of adverse effects can be increased when Canrenone is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB12670",
                        "description": "The risk or severity of adverse effects can be increased when Rolofylline is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB12704",
                        "description": "The risk or severity of adverse effects can be increased when Spiradoline is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "The risk or severity of adverse effects can be increased when Cicletanine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13284",
                        "description": "The risk or severity of adverse effects can be increased when Meticrane is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13405",
                        "description": "The risk or severity of adverse effects can be increased when Mefruside is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13430",
                        "description": "The risk or severity of adverse effects can be increased when Mebutizide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "The risk or severity of adverse effects can be increased when Cyclopenthiazide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13617",
                        "description": "The risk or severity of adverse effects can be increased when Clorexolone is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13663",
                        "description": "The risk or severity of adverse effects can be increased when Clofenamide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13708",
                        "description": "The risk or severity of adverse effects can be increased when Fenquizone is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13792",
                        "description": "The risk or severity of adverse effects can be increased when Clopamide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13801",
                        "description": "The risk or severity of adverse effects can be increased when Muzolimine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13803",
                        "description": "The risk or severity of adverse effects can be increased when Xipamide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13989",
                        "description": "The risk or severity of adverse effects can be increased when Epitizide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB14018",
                        "description": "The risk or severity of adverse effects can be increased when Bromotheophylline is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB14500",
                        "description": "The risk or severity of adverse effects can be increased when Potassium is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01345",
                        "description": "The risk or severity of adverse effects can be increased when Potassium cation is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB06694",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Xylometazoline"
                    },
                    {
                        "drugbank-id": "DB13650",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Aloglutamol"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Morphine"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Codeine"
                    },
                    {
                        "drugbank-id": "DB00327",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Hydromorphone"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Methadone"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Meperidine"
                    },
                    {
                        "drugbank-id": "DB00497",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Oxycodone"
                    },
                    {
                        "drugbank-id": "DB00611",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Butorphanol"
                    },
                    {
                        "drugbank-id": "DB00647",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Dextropropoxyphene"
                    },
                    {
                        "drugbank-id": "DB00652",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Pentazocine"
                    },
                    {
                        "drugbank-id": "DB00704",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Sufentanil"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Alfentanil"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Fentanyl"
                    },
                    {
                        "drugbank-id": "DB00844",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00854",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Levorphanol"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Remifentanil"
                    },
                    {
                        "drugbank-id": "DB00921",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Buprenorphine"
                    },
                    {
                        "drugbank-id": "DB00956",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Hydrocodone"
                    },
                    {
                        "drugbank-id": "DB01081",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Diphenoxylate"
                    },
                    {
                        "drugbank-id": "DB01192",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Oxymorphone"
                    },
                    {
                        "drugbank-id": "DB01209",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Dezocine"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Levacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01433",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Methadyl acetate"
                    },
                    {
                        "drugbank-id": "DB01450",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Dihydroetorphine"
                    },
                    {
                        "drugbank-id": "DB01452",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Diamorphine"
                    },
                    {
                        "drugbank-id": "DB01459",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Bezitramide"
                    },
                    {
                        "drugbank-id": "DB01466",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Ethylmorphine"
                    },
                    {
                        "drugbank-id": "DB01497",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Etorphine"
                    },
                    {
                        "drugbank-id": "DB01529",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Dextromoramide"
                    },
                    {
                        "drugbank-id": "DB01531",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Desomorphine"
                    },
                    {
                        "drugbank-id": "DB01535",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Carfentanil"
                    },
                    {
                        "drugbank-id": "DB01551",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Dihydrocodeine"
                    },
                    {
                        "drugbank-id": "DB01555",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Alphacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01565",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Dihydromorphine"
                    },
                    {
                        "drugbank-id": "DB06204",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Tapentadol"
                    },
                    {
                        "drugbank-id": "DB06738",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Ketobemidone"
                    },
                    {
                        "drugbank-id": "DB08861",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with DPDPE"
                    },
                    {
                        "drugbank-id": "DB09174",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Lofentanil"
                    },
                    {
                        "drugbank-id": "DB09272",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Eluxadoline"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Opium"
                    },
                    {
                        "drugbank-id": "DB11609",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Normethadone"
                    },
                    {
                        "drugbank-id": "DB12492",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Piritramide"
                    },
                    {
                        "drugbank-id": "DB13160",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Alphaprodine"
                    },
                    {
                        "drugbank-id": "DB13454",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Nicomorphine"
                    },
                    {
                        "drugbank-id": "DB13478",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Meptazinol"
                    },
                    {
                        "drugbank-id": "DB13605",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Phenoperidine"
                    },
                    {
                        "drugbank-id": "DB13606",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Phenazocine"
                    },
                    {
                        "drugbank-id": "DB13787",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Tilidine"
                    },
                    {
                        "drugbank-id": "DB15360",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Carfentanil C 11"
                    },
                    {
                        "drugbank-id": "DB15465",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Benzhydrocodone"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Oliceridine"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Cyclosporine is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00314",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Capreomycin is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00319",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Piperacillin is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00452",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00512",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Vancomycin is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00560",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Tigecycline is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00684",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Tobramycin is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00798",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Gentamicin is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00955",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Netilmicin is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00994",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Neomycin is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Procainamide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01082",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Streptomycin is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01111",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Colistimethate is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01172",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Kanamycin is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01190",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01219",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Dantrolene is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01301",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Rolitetracycline is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01421",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Paromomycin"
                    },
                    {
                        "drugbank-id": "DB01627",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Lincomycin"
                    },
                    {
                        "drugbank-id": "DB03615",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Ribostamycin"
                    },
                    {
                        "drugbank-id": "DB04263",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Geneticin"
                    },
                    {
                        "drugbank-id": "DB04626",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Apramycin"
                    },
                    {
                        "drugbank-id": "DB04729",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Gentamicin C1a"
                    },
                    {
                        "drugbank-id": "DB04808",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Neamine"
                    },
                    {
                        "drugbank-id": "DB06696",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Arbekacin"
                    },
                    {
                        "drugbank-id": "DB06827",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Viomycin"
                    },
                    {
                        "drugbank-id": "DB08437",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Puromycin"
                    },
                    {
                        "drugbank-id": "DB09407",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Magnesium chloride"
                    },
                    {
                        "drugbank-id": "DB11230",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Magnesium Aluminum Silicate"
                    },
                    {
                        "drugbank-id": "DB11512",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Dihydrostreptomycin"
                    },
                    {
                        "drugbank-id": "DB11520",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Hygromycin B"
                    },
                    {
                        "drugbank-id": "DB12604",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Sisomicin"
                    },
                    {
                        "drugbank-id": "DB12615",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Plazomicin"
                    },
                    {
                        "drugbank-id": "DB13249",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13359",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Magnesium aspartate"
                    },
                    {
                        "drugbank-id": "DB13540",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Isepamicin"
                    },
                    {
                        "drugbank-id": "DB13749",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Magnesium gluconate"
                    },
                    {
                        "drugbank-id": "DB13786",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Magnesium orotate"
                    },
                    {
                        "drugbank-id": "DB13862",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Magnesium phosphate"
                    },
                    {
                        "drugbank-id": "DB11110",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium citrate is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB09104",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium hydroxide is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01378",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Magnesium cation"
                    },
                    {
                        "drugbank-id": "DB09281",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Magnesium trisilicate"
                    },
                    {
                        "drugbank-id": "DB09409",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Magnesium acetate tetrahydrate"
                    },
                    {
                        "drugbank-id": "DB13996",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Magnesium acetate"
                    },
                    {
                        "drugbank-id": "DB14077",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Magnesium oxide is combined with Magnesium stearate"
                    },
                    {
                        "drugbank-id": "DB00803",
                        "description": "The risk or severity of neuromuscular blockade can be increased when Colistin is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00042",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Botulinum Toxin Type B"
                    },
                    {
                        "drugbank-id": "DB00083",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Botulinum toxin type A"
                    },
                    {
                        "drugbank-id": "DB00184",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Nicotine"
                    },
                    {
                        "drugbank-id": "DB01090",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Pentolinium"
                    },
                    {
                        "drugbank-id": "DB01116",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Trimethaphan"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Hexamethonium"
                    },
                    {
                        "drugbank-id": "DB08999",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Cyclopentamine"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Acetaminophen resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Propacetamol resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01390",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Sodium bicarbonate"
                    },
                    {
                        "drugbank-id": "DB06723",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB13209",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB13280",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Aluminium acetoacetate"
                    },
                    {
                        "drugbank-id": "DB13322",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Hydrotalcite"
                    },
                    {
                        "drugbank-id": "DB13595",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Almasilate"
                    },
                    {
                        "drugbank-id": "DB13626",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Aluminium glycinate"
                    },
                    {
                        "drugbank-id": "DB13829",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Calcium silicate"
                    },
                    {
                        "drugbank-id": "DB14517",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Aluminium phosphate"
                    },
                    {
                        "drugbank-id": "DB01638",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Sorbitol"
                    },
                    {
                        "drugbank-id": "DB09287",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Polyethylene glycol"
                    },
                    {
                        "drugbank-id": "DB09472",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Sodium sulfate"
                    },
                    {
                        "drugbank-id": "DB12942",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Lactitol"
                    },
                    {
                        "drugbank-id": "DB09462",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Glycerin"
                    },
                    {
                        "drugbank-id": "DB13526",
                        "description": "The therapeutic efficacy of Pentaerithrityl can be decreased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13707",
                        "description": "The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13486",
                        "description": "The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB09484",
                        "description": "The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB14482",
                        "description": "The therapeutic efficacy of Sodium ascorbate can be decreased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB14499",
                        "description": "The therapeutic efficacy of Potassium sulfate can be decreased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB14502",
                        "description": "The therapeutic efficacy of Sodium phosphate dibasic can be decreased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB14503",
                        "description": "The therapeutic efficacy of Sodium phosphate monobasic unspecified form can be decreased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB14504",
                        "description": "The therapeutic efficacy of Sodium phosphate dibasic unspecified form can be decreased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB14516",
                        "description": "The therapeutic efficacy of Sodium cation can be decreased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB14546",
                        "description": "The therapeutic efficacy of Sulfate ion can be decreased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00809",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Tropicamide"
                    },
                    {
                        "drugbank-id": "DB00941",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Hexafluronium"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Desloratadine"
                    },
                    {
                        "drugbank-id": "DB00979",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Cyclopentolate"
                    },
                    {
                        "drugbank-id": "DB01288",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Fenoterol"
                    },
                    {
                        "drugbank-id": "DB11181",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Homatropine"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Butabarbital"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Butalbital"
                    },
                    {
                        "drugbank-id": "DB00306",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Talbutal"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Pentobarbital"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Secobarbital"
                    },
                    {
                        "drugbank-id": "DB00463",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Metharbital"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Fluoxetine"
                    },
                    {
                        "drugbank-id": "DB00514",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Dextromethorphan"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Thiopental"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Procaine"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Isoflurane"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Primidone"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Amantadine"
                    },
                    {
                        "drugbank-id": "DB01161",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Chloroprocaine"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Amobarbital"
                    },
                    {
                        "drugbank-id": "DB01352",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Aprobarbital"
                    },
                    {
                        "drugbank-id": "DB01353",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Butobarbital"
                    },
                    {
                        "drugbank-id": "DB01354",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Heptabarbital"
                    },
                    {
                        "drugbank-id": "DB01355",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Hexobarbital"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Barbital"
                    },
                    {
                        "drugbank-id": "DB01496",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Dihydro 2 thioxo 5 5 2 trifluoromethyl phenyl 2 furanyl methyl 4 6 1H 5H pyrimidinedione"
                    },
                    {
                        "drugbank-id": "DB05710",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Gantacurium"
                    },
                    {
                        "drugbank-id": "DB00254",
                        "description": "The absorption of Doxycycline can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The absorption of Gemifloxacin can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Voriconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01110",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Miconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06395",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Abafungin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06440",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Ravuconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06636",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Isavuconazonium resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12073",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Albaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB04794",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Bifonazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Isavuconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Mephenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Methylphenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Phenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Nelfinavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00224",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Ritonavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00701",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Amprenavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Tipranavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Saquinavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01264",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Darunavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01319",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Fosamprenavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Asunaprevir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB15623",
                        "description": "Magnesium oxide can cause a decrease in the absorption of TMC 310911 resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Rilpivirine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00581",
                        "description": "The therapeutic efficacy of Lactulose can be decreased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The absorption of Palbociclib can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Dexmethylphenidate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12147",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Erdafitinib"
                    },
                    {
                        "drugbank-id": "DB04816",
                        "description": "The risk or severity of adverse effects can be increased when Dantron is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB04823",
                        "description": "The risk or severity of adverse effects can be increased when Oxyphenisatin is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB09311",
                        "description": "The risk or severity of adverse effects can be increased when Polycarbophil is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB11059",
                        "description": "The risk or severity of adverse effects can be increased when Carboxymethylcellulose is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB11097",
                        "description": "The risk or severity of adverse effects can be increased when Plantago seed is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB11113",
                        "description": "The risk or severity of adverse effects can be increased when Castor oil is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB11365",
                        "description": "The risk or severity of adverse effects can be increased when Sennosides is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB11057",
                        "description": "The risk or severity of adverse effects can be increased when Mineral oil is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB11228",
                        "description": "The risk or severity of adverse effects can be increased when Methylcellulose is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB04824",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Phenolphthalein"
                    },
                    {
                        "drugbank-id": "DB09219",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Bisoxatin"
                    },
                    {
                        "drugbank-id": "DB01046",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Lubiprostone"
                    },
                    {
                        "drugbank-id": "DB08890",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Linaclotide"
                    },
                    {
                        "drugbank-id": "DB06480",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Prucalopride"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Tegaserod"
                    },
                    {
                        "drugbank-id": "DB13170",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Plecanatide"
                    },
                    {
                        "drugbank-id": "DB14232",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Deacetylbisacodyl"
                    },
                    {
                        "drugbank-id": "DB14585",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Plantago ovata seed"
                    },
                    {
                        "drugbank-id": "DB14627",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Oxyphenisatin acetate"
                    },
                    {
                        "drugbank-id": "DB14684",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Calcium polycarbophil"
                    },
                    {
                        "drugbank-id": "DB07715",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Emodin"
                    },
                    {
                        "drugbank-id": "DB14963",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Konjac mannan"
                    },
                    {
                        "drugbank-id": "DB15477",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Alloin"
                    },
                    {
                        "drugbank-id": "DB15478",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Frangula purshiana bark"
                    },
                    {
                        "drugbank-id": "DB11622",
                        "description": "The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Dehydrocholic acid"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The serum concentration of Digoxin can be decreased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "The serum concentration of Metildigoxin can be decreased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The serum concentration of Acetyldigoxin can be decreased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00535",
                        "description": "The therapeutic efficacy of Cefdinir can be decreased when used in combination with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Mycophenolate mofetil resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "Naproxen can cause a decrease in the absorption of Magnesium oxide resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Hydroxychloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00996",
                        "description": "The bioavailability of Gabapentin can be decreased when combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "The serum concentration of Magnesium can be decreased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB15685",
                        "description": "The serum concentration of Selpercatinib can be decreased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Octreotide resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}